Story by Syracuse.com 4/19/22
Katya Sverdlov is co-founder and CEO of JelikaLite, a medical technology company focusing on pediatric neurological health, especially treatment for autism. It has developed an autism treatment, Cognilum, which received “Breakthrough Device Designation” from the FDA in January.